ID   HLN-STL-C
AC   CVCL_X751
SY   STL-C
DR   Wikidata; Q54889859
RX   PubMed=2551312;
RX   PubMed=8263111;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 9
//
RX   PubMed=2551312; DOI=10.1016/0896-8411(89)90175-3;
RA   Nagasaki, Makoto
RA   Morikawa, Shigeru
RA   Harada, Takayuki
RA   Miyasaka, Nobuyuki
RT   "A novel EBV-related nucleo-cytoplasmic antigen in a null cell-line
RT   (HLN-STL-C) reactive to antibodies in the sera from patients with
RT   Sjogren's syndrome.";
RL   J. Autoimmun. 2:457-462(1989).
//
RX   PubMed=8263111; DOI=10.1016/0166-0934(93)90050-2;
RA   Hironaka, Takashi
RA   Nagasaki, Makoto
RA   Morikawa, Shigeru
RA   Hirai, Kanji
RT   "Detection of Epstein-Barr virus transcripts in chemically or
RT   immunologically-activated cells and in a null cell-line (HLN-STL-C) by
RT   in situ hybridization with alkaline phosphatase-linked oligonucleotide
RT   probes.";
RL   J. Virol. Methods 44:141-154(1993).
//